TMCnet News
Bovie Medical Corporation First Quarter 2014 Earnings Conference Call to be Held on Thursday, May 15, 2014CLEARWATER, Fla. --(Business Wire)-- Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, today announced that it will issue its financial results for the first quarter ended March 31, 2014 following the close of market on Thursday, May 15, 2014. Management will host a conference call on Thursday, May 15, 2014, at 4:30 pm Eastern Time to discuss latest corporate developments. Following management's formal remarks, there will be a question and answer session. To listen to the call by phone, interested parties within the U.S. should call 1-877-317-6789. International callers should call 1-412-317-6789. All callers should ask for the Bovie Medical Corporation conference call. The conference call will also be available through a live webcast at Bovie Medical Corporation's website or at http://services.choruscall.com/links/bvx140515.html. A replay of the call will be available approximately one hour after the end of the call through June 15, 2014. The replay can be accessed via Bovie Medical Corporation's website. About Bovie Medical Corporation Bovie Medical Corporation is a leading maker of medical devices and supplies as well as the developer of J-Plasma®, a patented new plasma-based surgical product. J-Plasma® utilizes a gas ionization process that produces a stable, focused beam of ionized gas that provides surgeons with greater precision, minimal invasiveness and an absence of conductive currents during surgery. Bovie Medical Corporation is also a leader in the manufacture of a range of electrosurgical products and technologies, marketed through both private labels and the Company's own well-respected brands (Bovie®, Aaron®, IDS™ and ICON™) to distributors worldwide. The Company also leverages its expertise through original equipment manufacturing (OEM) agreements with other medical device manufacturers. For further information about the Company's current and new products, please refer to the Investor Relations section of Bovie Medical Corporation's website www.boviemed.com.
|
